Biogen’s higher dose Spinraza under review by US and EU regulators – Pharmaceutical Technology
Spinal muscular atrophy (SMA) is a rare genetic condition that can cause muscle weakness. Credit: KATERYNA KON/SCIENCE PHOTO LIBRARY via Getty Images. The US Food